Epidemiology of invasive mold infections in lung transplant recipients

American Journal of Transplantation

Volumn 14, Issue 6, 2014, Pages 1328-1333

  Doligalski, C T ^a   Benedict, K ^b   Cleveland, A A ^b   Park, B ^b   Derado, G ^c   Pappas, P G ^d   Baddley, J W ^d   Zaas, D W ^e   Harris, M T ^e   Alexander, B D ^e  

^a TAMPA GENERAL HOSPITAL   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^d University of Alabama at Birmingham   (United States)

^e DUKE UNIVERSITY HOSPITAL   (United States)

Author keywords

Epidemiology; infection; lung transplant; mold

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCONAZOLE; ITRACONAZOLE; KETOCONAZOLE; VORICONAZOLE;

AGED; ARTICLE; ASPERGILLOSIS; ASPERGILLUS; COUGHING; DYSPNEA; FEMALE; GRAFT RECIPIENT; HUMAN; INCIDENCE; INVASIVE ASPERGILLOSIS; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MOULD; MUCORMYCOSIS; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; SCEDOSPORIUM; CLINICAL TRIAL; COHORT ANALYSIS; LUNG DISEASES; MICROBIOLOGY; MULTICENTER STUDY; MYCOSES;

COHORT STUDIES; HUMANS; LUNG DISEASES; LUNG TRANSPLANTATION; MYCOSES;

EID: 84901327456     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.12691     Document Type: Article

References (20)

1. 2011 Annual Report of the US Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: Transplant Data 1994-2011. Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation, Rockville, MD; United Network for Organ Sharing, Richmond, VA; University Renal Research and Education Association, Ann Arbor, MI.
2. Grossi P, Farina C, Fiocchi R, Dalla Gasperina D., Prevalence and outcome of invasive fungal infections in 1963 thoracic organ transplant recipients: A multicenter retrospective study. Italian Study Group of Fungal Infections in Thoracic Organ Transplant Recipients. Transplantation 2000; 70: 112-116. (Pubitemid 30490761)
3. Iversen M, Burton CM, Vand S, et al. Aspergillus infection in lung transplant patients: Incidence and prognosis. Eur J Clin Microbiol Infect Dis 2007; 26: 879-886. (Pubitemid 350077208)
4. Pugliese F, Ruberto F, Cappannoli A, et al. Incidence of fungal infections in a solid organ recipients dedicated intensive care unit. Transplant Proc 2007; 39: 2005-2007. (Pubitemid 47198823)
5. Radack KP, Alexander BD., Prophylaxis of invasive mycoses in solid organ transplantation. Curr Infect Dis Rep 2009; 11: 427-434.
6. Gavalda J, Len O, San Juan R, et al. Risk factors for invasive aspergillosis in solid-organ transplant recipients: A case control study. Clin Infect Dis 2005; 41: 52-59. (Pubitemid 40863744)
7. Solé A, Morant P, Salavert M, Pemán J, Morales P, Valencia Lung Transplant Group. Aspergillus infections in lung transplant recipients: Risk factors and outcome. Clin Microbiol Infect 2005; 11: 359-365. (Pubitemid 40575818)
8. Pappas PG, Alexander BD, Andes DR, et al. Invasive fungal infections among organ transplant recipients: Results of the Transplant-Associated Infection Surveillance Network (TRANSNET). Clin Infect Dis 2010; 50: 1101-1111.
9. De Pauw B, Walsh TJ, Donnelly JP, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008; 46: 1812-1821.
10. Arthurs SK, Eid AJ, Deziel PJ, et al. The impact of invasive fungal diseases on survival after lung transplantation. Clin Transplant 2010; 24: 341-348.
11. Neofytos D, Fishman JA, Horn D, et al. Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients. Transpl Infect Dis 2010; 12: 220-229.
12. Baddley JW, Andes DR, Marr KA, et al. Factors associated with mortality in transplant patients with invasive aspergillosis. Clin Infect Dis 2010; 50: 1559-1567.
13. Blot SI, Taccone FS, Van den Abeele AM, et al. A clinical algorithm to diagnose invasive pulmonary aspergillosis in critically ill patients. Am J Respir Crit Care Med 2012; 186: 56-64.
14. AST Infectious Disease Community of Practice. Fungal infections. Am J Transplant 2004; 4 (Suppl 10): 110-134.
15. Husain S, Zaldonis D, Kusne S, Kwak EJ, Paterson DL, McCurry KR., Variation in antifungal prophylaxis strategies in lung transplantation. Transpl Infect Dis 2006; 8: 213-218. (Pubitemid 44787860)
16. Neoh CF, Snell GI, Kotsimbos T, et al. Antifungal prophylaxis in lung transplantation-A world-wide survey. Am J Transplant 2011; 11: 361-366.
17. Singh N, Husain S, AST Infectious Diseases Community of Practice. Invasive aspergillosis in solid organ transplant recipients. Am J Transplant 2009; 9: S180-S191.
18. Gordon SM, Avery RK., Aspergillosis in lung transplantation: Incidence, risk factors, and prophylactic strategies. Transpl Infect Dis 2001; 3: 161-167. (Pubitemid 32756698)
19. Avery RK, Michaels MG, AST Infectious Diseases Community of Practice. Strategies for safe living following solid organ transplantation. Am J Transplant 2009; 9 (Suppl 4): S252-S257.
20. Pfeiffer CD, Perfect JR, Alexander BA., Current controversies in the treatment of fungal infections. In:, Safdar A, ed. Principles and practice of cancer infectious diseases (current clinical oncology). New York, NY: Humana Press, 2011, pp. 301-316.